Cancer Antibodies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
48
NCT05150457
Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 8, 2022
Completion: Nov 30, 2025
Loading map...